Quest Diagnostics Aktie

Quest Diagnostics für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 904533 / ISIN: US74834L1008

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
12.03.2014 14:40:00

Quest Diagnostics Incorporated -- Moody's rates Quest's proposed sr. notes Baa2

New York, March 12, 2014 -- Moody's Investors Service assigned a Baa2 rating to Quest Diagnostics Incorporated's (Quest) proposed offering of a total of $600 million senior unsecured notes due 2019 and 2024. The stable rating outlook is unchanged. Moody's expects the proceeds to be used to repay amounts outstanding under the company's revolving credit facility and accounts receivable securitization facility that were utilized to fund the closing of the acquisition of Solstas Lab Partners Group.

Vollständigen Artikel bei Moodys lesen